300082.SHE Liaoning Oxiranchem Inc
- Market cap
- CNY 4.60B
- P/E
- 42.3x
- P/B
- 1.59x
- ROE
- 4.4%
- Dividend yield
- 1.22%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300082.SHE undervalued?
Graham number300082.SHE trades 73.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Liaoning Oxiranchem Inc fundamental analysis
No fundamental analysis for Liaoning Oxiranchem Inc yet.
Liaoning Oxiranchem Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Liaoning Oxiranchem Inc
Liaoning Oxiranchem,Inc. engages in the research and development, production, and sale of high-end and ethylene oxide derivative fine chemicals in China and internationally. The company offers crystalline silicon cutting liquids; water reducing agents polyether; polyether monomers and polyol; ethylene carbonate products; alcohol ether; dimethyl carbonate; alcohol amine polyether; and polyethylene glycol. It also provides functional additives, epoxy sterilization, medicinal e…
Full company profileLiaoning Oxiranchem Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Liaoning Oxiranchem Inc annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 4.35B | 5.70B | 7.45B | 6.39B | 5.71B | 6.72B | 5.64B | 3.81B | 4.29B | 4.23B | 4.73B |
| Gross Profit | 415M | 571M | 803M | 783M | 743M | 647M | 239M | -55.2M | 110M | 205M | 344M |
| Operating Income | -15.7M | 263M | 414M | 443M | 520M | 423M | 22.1M | -349M | -164M | 24.1M | 116M |
| EBITDA | 280M | 527M | 706M | 732M | 777M | 707M | 331M | -35.6M | 91.8M | 274M | 219M |
| Net Income | 76.3M | 209M | 326M | 352M | 403M | 352M | 5.60M | -309M | -159M | 6.80M | 124M |
| EPS | 0.11 | 0.31 | 0.48 | 0.52 | 0.59 | 0.52 | 0.01 | -0.45 | -0.23 | 0.01 | 0.18 |
| Balance Sheet | |||||||||||
| Total Assets | 5.32B | 6.30B | 5.60B | 4.88B | 5.43B | 6.76B | 6.42B | 5.52B | 5.73B | 5.80B | 6.10B |
| Total Liabilities | 2.46B | 3.16B | 2.33B | 1.46B | 1.92B | 3.06B | 2.92B | 2.34B | 2.74B | 2.82B | 3.02B |
| Shareholders' Equity | 2.67B | 2.86B | 3.08B | 3.22B | 3.28B | 3.45B | 3.25B | 2.94B | 2.76B | 2.74B | 2.83B |
| Cash & Short-term Investments | 760M | 864M | 722M | 713M | 821M | 969M | 649M | 504M | 934M | 696M | 837M |
| Total Debt | 1.31B | 1.59B | 1.25B | 617M | 805M | 1.42B | 1.54B | 1.51B | 1.62B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 216M | 139M | 720M | 1.25B | 623M | 497M | 306M | 86.7M | -39.7M | -466M | - |
| Capital Expenditure | 75.6M | 238M | 28.5M | 103M | 366M | 487M | 258M | 70.0M | 28.2M | 20.6M | 36.3M |
| Free Cash Flow | 141M | -98.7M | 692M | 1.15B | 257M | 10.3M | 48.5M | 16.7M | -67.8M | -487M | -228M |
| Ratios | |||||||||||
| ROE | 2.9% | 7.3% | 10.6% | 10.9% | 12.3% | 10.2% | 0.2% | -10.5% | -5.8% | 0.2% | 4.4% |
| ROA | 1.4% | 3.3% | 5.8% | 7.2% | 7.4% | 5.2% | 0.1% | -5.6% | -2.8% | 0.1% | 2.0% |
| Net Profit Margin | 1.8% | 3.7% | 4.4% | 5.5% | 7.1% | 5.2% | 0.1% | -8.1% | -3.7% | 0.2% | 2.6% |
| Debt to Equity | 0.49x | 0.56x | 0.41x | 0.19x | 0.25x | 0.41x | 0.47x | 0.51x | 0.59x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Liaoning Oxiranchem Inc dividends
- Dividend yield
- 1.22%
- Forward dividend
- -
- Payout ratio
- 825.2%
- Ex-dividend date
- May 31, 2022
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 56.1M | 0.08 | 825.2% |
| 2024 | CNY 52.1M | 0.08 | - |
| 2023 | CNY 49.9M | 0.07 | - |
| 2022 | CNY 233M | 0.42 | 4,157.7% |
| 2021 | CNY 243M | 0.36 | 68.9% |
| 2020 | CNY 243M | 0.36 | 60.3% |
| 2019 | CNY 228M | 0.34 | 64.8% |
| 2018 | CNY 169M | 0.25 | 51.9% |
| 2017 | CNY 105M | 0.16 | 50.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 20:10 on May 20, 2015.
Who owns Liaoning Oxiranchem Inc
- Insiders 61.19%
- Institutions 0.10%
- Public & others 38.72%
- Shares outstanding 680M
- Free float 288M
Liaoning Oxiranchem Inc company profile
- Company name
- Liaoning Oxiranchem Inc
- Ticker
- 300082.SHE
- ISIN
- CNE100000PC9
- Exchange
- Shenzhen Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,362
- Fiscal year end
- December
- Address
- No. 38 Wanhe 7th Road, Liaoyang, China, 111003
- Phone
- 86 41 9558 8863
- Website
- oxiranchem.com
About Liaoning Oxiranchem Inc
Liaoning Oxiranchem,Inc. engages in the research and development, production, and sale of high-end and ethylene oxide derivative fine chemicals in China and internationally. The company offers crystalline silicon cutting liquids; water reducing agents polyether; polyether monomers and polyol; ethylene carbonate products; alcohol ether; dimethyl carbonate; alcohol amine polyether; and polyethylene glycol. It also provides functional additives, epoxy sterilization, medicinal excipients, new battery materials, green and nonionic surfactants, and food grade carbon dioxide. Its products are used in construction for infrastructure projects, such as high-speed railway lines, subway underground construction, airports and expressways, cleaning agents, washing powders, pharmaceuticals, electronic materials, automotive, textiles, printing inks, dyes, and other fileds. Liaoning Oxiranchem,Inc. was incorporated in 2000 and is headquartered in Liaoyang, China. Liaoning Oxiranchem,Inc. operates as a subsidiary of Oxiranchem Holding Group Co., Ltd.
Liaoning Oxiranchem Inc management
7- Mr. Zong Jiang ZhuPresident · born 1972
- Ms. Dongmei LiuFinancial Director & Accounting Supervisor · born 1982
- Mr. Yangying ChenEmployee Representative Director & VP · born 1976
- Mr. Shuai MaVP & Board Secretary · born 1984
- Mr. Yang GuangVice President · born 1986
- Mr. Hong Bo YuVice President · born 1973
- Mr. Shu Bo WangVice President · born 1969